JALYN BYRD: Open Payments
NPI 1346655180 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,185 in 23 payments from 7 companies in 2025. Trend: 2023 $794 · 2024 $651 · 2025 $1,185
Food & beverage: $1,185
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $610 |
| Corcept Therapeutics | 7 | $287 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $209 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
Products named: Korlym, FARXIGA, AIRSUPRA, CAPLYTA, BREZTRI, REXULTI, Veozah, INSPIRE.
Industry payments across OK — which companies pay providers there.
